Sandra Silberman

Directeur Technique/Scientifique/R&D chez MOLECULIN BIOTECH, INC.

Fortune : 1 745 $ au 30/04/2024

69 ans

Health Technology

Consumer Services

Postes actifs de Sandra Silberman

Sociétés	Poste	Début	Fin
MOLECULIN BIOTECH, INC.	Directeur Technique/Scientifique/R&D	08/11/2017	-
CNS PHARPAR	Directeur Technique/Scientifique/R&D	01/12/2017	-

Sociétés	Poste	Début	Fin
Eisai Medical Research, Inc.	Corporate Officer/Principal	01/01/2004	-
Novartis Corp. Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.	Directeur Technique/Scientifique/R&D	01/01/2000	-
SCORPIUS HOLDINGS, INC.	Directeur Technique/Scientifique/R&D	01/01/2013	-

Weill Cornell Medical College	Doctorate Degree
The Johns Hopkins University School of Medicine	Doctorate Degree
Zanvyl Krieger School of Arts & Sciences	Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Chief Tech/Sci/R&D Officer	4
Doctorate Degree	2
Corporate Officer/Principal	1

Sectorielle

Health Technology	5
Consumer Services	4

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	2
Novartis Corp. Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.	Health Technology
Eisai Medical Research, Inc.